Phase II evaluation of anguidine (NSC 141537) in 5-day courses in colorectal adenocarcinoma. A Southeastern Cancer Study Group Trial.

Source:http://linkedlifedata.com/resource/pubmed/id/3728370

Download in:

View as

General Info

PMID
3728370